Cardiovascular Disease Risk Factors

We extracted information on each subject on demographics, survey data, cholesterol, LDL-C, and triglyceride levels, as well as use of statins and PCSK9 inhibitor use. ASCVD was defined based on all listed manifestations of coronary artery disease, cerebrovascular disease (excluding hemorrhagic stroke), and peripheral arterial disease. Statin use was defined as a documented prescription (generic or branded) of atorvastatin, cerivastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and/or simvastatin. Statin intensity was categorized into those at high and low/moderate intensities according to US guidelines [12 (link)]. Ezetimibe and icosapent ethyl use was also captured, and PCSK9 inhibitors included evolocumab and alirocumab. We additionally obtained survey data on health insurance status, types of health insurance, BMI, education level, cigarette smoking status, and income.